Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
Background: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Brain Stimulation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X17309464 |
id |
doaj-0bb618677f66462c8103fd78db62bcf7 |
---|---|
record_format |
Article |
spelling |
doaj-0bb618677f66462c8103fd78db62bcf72021-03-19T07:11:20ZengElsevierBrain Stimulation1935-861X2018-01-011112951Electroconvulsive therapy, depression, the immune system and inflammation: A systematic reviewAntoine Yrondi0Marie Sporer1Patrice Péran2Laurent Schmitt3Christophe Arbus4Anne Sauvaget5Psychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, France; Toulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, France; Corresponding author. Service de psychiatrie et psychologie médicale, CHU Toulouse-Purpan, 330 avenue de Grande Bretagne, 31059 Toulouse, France.Psychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, FranceToulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, FrancePsychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, FrancePsychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, France; Toulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, FranceCHU Nantes, Addictology and Liaison Psychiatry Department, Neuromodulation Unit in Psychiatry, Nantes, FranceBackground: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of the immune response. Among the treatments for depression ECT occupies an important place. The underlying cerebral mechanisms of ECT remain unclear. Objectives/Hypothesis: The aim of this review is to survey the potential actions of ECT on the immuno-inflammatory cascade activated during depression. Methods: A systematic search of the literature was carried out, using the bibliographic search engines PubMed and Embase. The search covered articles published up until october 2017.The following MESH terms were used: Electroconvulsive therapy AND (inflammation OR immune OR immunology). Results: Our review shows that there is an acute immuno-inflammatory response immediately following an ECT session. There is an acute stress reaction. Studies show an increase in the plasma levels of cortisol and of interleukins 1 and 6. However, at the end of the course of treatment, ECT produces, in the long term, a fall in the plasma level of cortisol, a reduction in the levels of TNF alpha and interleukin 6. Limitations: One of the limitations of this review is that a large number of studies are relatively old, with small sample sizes and methodological bias. Conclusion: Advances in knowledge of the immuno-inflammatory component of depression seem to be paving the way towards models to explain the mechanism of action of ECT.http://www.sciencedirect.com/science/article/pii/S1935861X17309464Depressive disorderInflammationECTImmuneCortisol |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Antoine Yrondi Marie Sporer Patrice Péran Laurent Schmitt Christophe Arbus Anne Sauvaget |
spellingShingle |
Antoine Yrondi Marie Sporer Patrice Péran Laurent Schmitt Christophe Arbus Anne Sauvaget Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review Brain Stimulation Depressive disorder Inflammation ECT Immune Cortisol |
author_facet |
Antoine Yrondi Marie Sporer Patrice Péran Laurent Schmitt Christophe Arbus Anne Sauvaget |
author_sort |
Antoine Yrondi |
title |
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review |
title_short |
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review |
title_full |
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review |
title_fullStr |
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review |
title_full_unstemmed |
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review |
title_sort |
electroconvulsive therapy, depression, the immune system and inflammation: a systematic review |
publisher |
Elsevier |
series |
Brain Stimulation |
issn |
1935-861X |
publishDate |
2018-01-01 |
description |
Background: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of the immune response. Among the treatments for depression ECT occupies an important place. The underlying cerebral mechanisms of ECT remain unclear. Objectives/Hypothesis: The aim of this review is to survey the potential actions of ECT on the immuno-inflammatory cascade activated during depression. Methods: A systematic search of the literature was carried out, using the bibliographic search engines PubMed and Embase. The search covered articles published up until october 2017.The following MESH terms were used: Electroconvulsive therapy AND (inflammation OR immune OR immunology). Results: Our review shows that there is an acute immuno-inflammatory response immediately following an ECT session. There is an acute stress reaction. Studies show an increase in the plasma levels of cortisol and of interleukins 1 and 6. However, at the end of the course of treatment, ECT produces, in the long term, a fall in the plasma level of cortisol, a reduction in the levels of TNF alpha and interleukin 6. Limitations: One of the limitations of this review is that a large number of studies are relatively old, with small sample sizes and methodological bias. Conclusion: Advances in knowledge of the immuno-inflammatory component of depression seem to be paving the way towards models to explain the mechanism of action of ECT. |
topic |
Depressive disorder Inflammation ECT Immune Cortisol |
url |
http://www.sciencedirect.com/science/article/pii/S1935861X17309464 |
work_keys_str_mv |
AT antoineyrondi electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview AT mariesporer electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview AT patriceperan electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview AT laurentschmitt electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview AT christophearbus electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview AT annesauvaget electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview |
_version_ |
1724214143448252416 |